Educational Sessions

with

8:45am-10:15am
Friday, May 31
Plenary/Awards
 

SCABB Award Lectures
Administrative Award Lecture:   Dr. Merlyn Sayers


Technical Scientific Award Lecture:  CAR T therapies- where are we now?: Geeta Paranjape
Immune response/lack thereof has big role in development of cancer. Using T cells (self or non self) trained to fight cancer offers a great option in the treatment

10:30am-12:00 pm
Friday, May 31
T/S


 Hemostasis
Prehospital Transfusion and the Use of Low Titer O Whole Blood,  Donald Jenkins, MD
  Intended Audience:  ; Level:  

Managing Hemostasis and Coagulation on ECMO, Lisa Hench, MD (Pediatrics), Art Bracey, MD (Adults)
 Intended Audience:   Level:  

10:30am-12:00 pm
Friday, May 31

Admin

 
Session 1
How to fulfill your career goals in blood banking industry, Chad Douglas
 Intended Audience:  All; Level:  Basic

Overview of ACTS and how alliances support community blood programs, Nelson Hellwig
  Intended Audience:  Level:  

10:30am-12:00 pm
Friday, May 31
DRC
 
Session 1
Social Power outreach to all generations.. including outreach to Millennial, Heather Georgoudiou
  Intended Audience:  Managers/Directors, Collections, Recruitment; Level:  Basic​

Digital including outreach to Millennial Nikki Stephens
    Intended Audience:  Recruiters, Recruitment Managers, and Opperations Managers; Level:  Basic​

2:45pm-4:15pm
Friday, May 26
T/S

Virtual Session
Blood Components
Refrigerated (4C) Platelets: New Opportunities for Improving the Care of Bleeding Patients, Kristin Reddoch, MD 
The use of room temperature (RT) platelets (PLTs) for treatment of trauma, especially under austere environments, is sub-optimal due to a short shelf life, high risk of bacterial contamination, and decline in PLT function over storage. Cold storage (4C) of PLTs has re-emerged as a viable alternative to RT due to slower bacterial growth and better preservation of PLT function but also causes increased PLT activation. In this talk we will show data from our lab¿previously published and recent discoveries¿showcasing the superior hemostatic properties of cold-stored PLTs as well as ways to mitigate cold-stored PLT activation, namely through the use of platelet additive solutions (PASs).  Intended Audience:  General, Scientific; Level:  Basic

Serological Strategies for Solving the Sickle Cell Transfusion Puzzle, Nancy Benitez, MHS (ASCP)SBB

The majority of patients with Sickle Cell Anemia (SCD) requires transfusion at some point in their life to reduce complications. This session will describe strategies to find suitable donors to prevent alloimmunization of non-alloimmunized SCD patients. It will also outline serological tools to identify antibodies developed by chronically transfused patients. Our goal is to have enough antigen matched units available to provide compatible blood to this special group of patients. Case studies will supplement the review.  Intended Audience:  Lab Technologists, MD, Supervisors, Manager; Level:  Basic

Emerging Pathogens in Transfusion Medicine, Louis Katz, MD
This presentation will be a survey of the pathogens of greatest current and future interest and approaches to risk mitigation.  Intended Audience:  Blood Bankers; Level:  Intermediate
2:45pm-4:15pm
Friday, May 26

Admin
 
Blood Utilization
Patient Centric Transfusion, John Armitage, MD 
Patient Centric Transfusion (PCT) is a conceptual counterbalance to the possible dangers of rationing inherent in Patient Blood Management (PBM) methodologies. PCT aims to engage patients and family members as informed, collaborative decision makers in transfusion care.    Intended Audience:  All; Level:  Intermediate
 
Blood Utilization: a Blood Center Perspective, Greg Denomme, PhD, FCSMLS(D)
Blood centers provide ABO and antigen-negative blood product to meet the specific needs of transfusion recipients. In some instances it's convenient to use the universal O Negative blood donor for antigen-negative blood products when Rh positive blood would be appropriate. This practice causes excessive demand on O Negative blood donors. On the other hand, AB plasma contains neither anti-A or anti-B isoagglutinins and has become the "go to" product for transfusion in several disease states. However, antibody titer and other strategies have replaced the use of AB plasma. This presentation will outline ways that blood centers conserve these two valuable products and yet provide safe products to transfusion recipients.  Intended Audience:  MT's/MLT's, Supervisors, Administrators, Physicians; Level:  Basic

2:45pm-4:15pm
Friday, May 26

DRC
 
Recruitment Sales Skills & Account Development
Increasing Productivity Through Relationships , Ashley Herman, Michael Rogers
The presentation is intended to create dialog on unique methods to recruit and retain donors. This process is completed through communication, relationships, and leadership.  Intended Audience:  Recruitment and Collections ; Level:  Basic

Managing Donor Groups in Changing Environments, Tara Scott
​Join me as we walk through some tried and true steps to analyze your donor groups and market segments. We will briefly dive into each of these topics to help you better manage your groups and get the most out of all your accounts: Understanding Targets, Organization/Leadership, History, Recognition/Return, Donor Frequency. All of this together will make for a more successful recruiter and blood center!
We will talk about how to best asses your donor base and leverage these groups to net the most lifesavers possible. Take a step back with me and analyze your groups and ask yourself what can I be doing differently? What is already existing within my groups that I could use to benefit the blood donor program? Recruiters are known to run hard and work quickly, but slowing down and truly researching your own donor groups will save you time and your blood organization money in the long run!  Intended Audience:  Directors, Managers, Recruiters, Development, ; Level:  Basic


8:15am-9:30am
Saturday, May 27
Plenary/Awards

Virtual Session
Oral Abstracts
Effect of 0.2M Dithiothreitol on Red Cell Antigen Integrity on Reagent Red Blood Cells, Heike Carrel, Carter BloodCare:  Sol Haberman Award Winner​

Validation of Styrofoam Coolers for use During Massive Transfusion Protocol, Lauren King, MD, University of Oklahoma Medical Center

Maximize Apheresis Plasma, Geri Venable, LifeShare Blood Centers

Inactivation of T Lymphocytes in Platelets and Plasma Components using Amotosale, Adonis Stassinopoulos, Cerus Corporation  Presented by: Marion Lanteri

9:45am-11:15am
Saturday, May 27
T/S

Virtual Session
Patient Blood Management

AABB Platelet Guidelines- what does it mean to my practice?, Richard Gammon, MD
Each year 2.5 million platelet doses are administered with a cost of at least $2.5 billion. This session will cover the origin of platelet transfusion thresholds and current AABB recommendations. There will be a discussion of the causes of platelet refractoriness and approaches to patient treatment. Finally, a number of case presentations will allow the audience to apply what was learned during the session.  Intended Audience:  MT, MD; Level:  Basic

​The “D” Dilemma: How Do We Treat Weak Ds?, Joann Moulds, PhD, MT(ASCP)SBB
This lecture will review the classification and causes for weak D, partial D and Del. The recent AABB guidelines for transfusion of and the use of RhIgG for weak D patients will be presented. Several methods for RH genotyping will be discussed.  Intended Audience:  Physicians, Technologists; Level:  Intermediate

Polar Medical Operations - Utilization of a Walking Blood Bank, Barbara Bryant, MD, MT(ASCP)SBB
How do you provide emergency blood transfusions when you are geographically isolated? This presentation will discuss the development, training, and implementation of a Walking Blood Bank program located literally at the end of the Earth.  Intended Audience:  All; Level:  Basic
9:45am-11:15am
Saturday, May 27

Admin/DRC
 
Joint Session Admin & DRC
Engaging Donors from Start to Finish through Creative Unique Programs, Jackie Waldron, Tirah Zielinski
It all begins with donors connecting with OneBlood through our Share Your Story – I Am OneBlood initiative. 1st time donor engagement – thank you and power of blood type. O neg specific first time donor mailing – complete package of items, Milestone Program, Recognition at time of donation and post donation and Social Recognition.

Patient Centric Blood Utilization, John Armitage, MD
If you or a family member received blood would you like the opportunity to thank the blood donor who provided it? If you are a blood donor and received a thank you email from the person who received your blood, or their family member how would that make you feel? If you could make this happen for your blood center without the worry of HIPA would you do it? This presentation will show you the possibility of that magical connection between the donor and the patient.  Intended Audience:  Laboratory, recruitment, collections and center or hospital administrative management; Level:  Intermediate

1:30pm-3:00pm
Saturday, May 27
T/S

​Virtual Session
Case Studies
The Transfusion Reactions You Don’t Want, Richard Gammon, MD
This session will discuss two case studies in which transfusion reactions occurred. Recognition, treatment and prevention will be covered.  Intended Audience: All; Level: Intermediate

Donor/Therapeutic Apheresis Cases, Tina Ipe, MD
Donor apheresis is used in the collection of blood components. Therapeutic apheresis is used to treat a variety of medical disorders, which can be fatal without medical intervention. This didactic session will use cases to understand about the available apheresis modalities, important physiologic considerations, and adverse consequences of apheresis and interventions to minimize them.  Intended Audience: Physicians, fellows, residents and laboratory staff that perform donor and therapeutic apheresis ; Level: Basic

Variations on a Theme: Case Study of a Patient with Anti-U Antibody, Stephanie Bates, MD 
A female patient with Sickle Cell Disease presents with multiple antibodies, including an anti-U. She is actually a U antigen variant, and only U variant blood is available. This presentation will discuss her clinical course, complications and the plan for future transfusions and pregnancies.  Intended Audience: Technologists, physicians and students ; Level: Basic

Molecular Case Study, Roser Hoffman, MT(ASCP)SBBCM 
The presentation will describe a case where molecular and serological results are discrepant. The presentation will cover how alternate molecular methods can resolve the discrepancy.  Intended Audience: Blood Bank technologists and supervisors; Level: Intermediate


1:30pm-3:00pm
Saturday, May 27
Admin
 
Crisis Management
Preparing Staff, Citizens and Community for Disaster,  Thomas Bryer, PhD
The presentation will address three levels of concerns for preparing for and responding to disaster and crisis situations: individual, organizational, and community, and will include lessons for learning from disasters to improve future performance.  Intended Audience: Line staff and Managers; Level: Basic

Orlando Health Blood Bank Response to the Pulse Nightclub Disaster, Lourdes Miller, BS, MT(ASCP), Carol Fortier, MT (ASCP)
Learn how the ORMC blood bank responded when the Nation's worst mass shooting happened in their own back yard

1:30pm-3:00pm
Saturday, May 27
DRC
 

 
Creating Harmony with Donor recruitment and Collections
Building Trust and Accountability between Donor Recruitment and the Customer Facing Team,  Geri Venable
There has been a past precedent of donor services and donor recruitment not getting along. But why? Both teams have the same end goal in mind. Both teams need each other. Both teams are needed to make the organization successful. Education and communication goes a long way in helping both teams understand challenges that each face. With education comes knowledge.   

Donor iron stores and drawing red cells from females with hgb 12-12.4g/dl, Jed Gorlin, MD
With FDA update in CFR the minimum hemoglobin for males to donate was raised to 13g/dl. There was a suggestion that drawing females with hemoglobins 12-12.4 might be acceptable but only after FDA approved a proposal to protect donor iron stores and no details of what would be required for approval. AABB and ABC developed a joint taskforce to submit proposed strategies with and without ferritin testing to BPAC that were not well received. It remains unclear if FDA would approve any variance at this juncture.

3:15pm-4:30pm
Saturday, May 27

Plenary/Awards


Ask the Experts
Nancy Benitez, MHS (ASCP)SBB, Barbara Bryant, MD, MT(ASCP)SBB, Richard Gammon, MD, Joann Moulds, PhD, MT(ASCP)SBB
    


4:45pm-5:45pm
Saturday, May 27
T/S
 

 
MD Roundtable
The session consists of discussions moderated by Dr. Bracey and Dr. Chen on hot topics in Transfusion Medicine chosen by the participants and the moderator. Different practices on how to address current issues are compared, giving rise to potential improvement in practices.  Making contact with other medical directors in the area allows for future interactions and resources when issues occur. 
10:00am-11:00am
Sunday, May 28
Plenary/Awards

Virtual Session
Karen Williams Memorial Lecturer 
KWML Award Lecture:  “First, Do No Harm………..”, Joann Moulds, PhD 
Blood safety is often used in the context of infectious disease. But the goal of safe transfusion should apply equally to the red cell which themselves can cause life-threatening problems. This lecture will discuss the questions: Are we really succeeding in mitigating risks associated with red cell transfusion and what more can be done to decrease this risk?
11:00am-12:00pm
Sunday, May 28
Plenary/Awards

Virtual Session
Closing Plenary 
Personal and Professional Excellence, Exploration and Evolution, Story Musgrave, MD
Musgrave will motivate and inspire you how to figure it out and get the job done right the first time and every time. That is, producing and inspiring a talented, proficient team of professionals to bring the total situation and system to some desired and prescribed outcome. That is, being on same playing field: learning the rules of the game, acquiring a plan and acquiring the skillset to execute that plan with ownership and passion to get to the goal. ​